Annals of Indian Academy of Neurology
  Users Online: 1373 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
LETTER TO THE EDITOR
Year : 2020  |  Volume : 23  |  Issue : 7  |  Page : 43-44
 

COVID-19 and underlying cerebrovascular disease: Analysis on association


1 TWS Medical Center, Bangkok, Thailand
2 Honorary Professor, Dr DY Patil University, Pune, India; Visiting Professor, Hainan Medical University, Haikou, China

Date of Submission09-Apr-2020
Date of Decision09-Apr-2020
Date of Acceptance06-Apr-2020
Date of Web Publication17-Apr-2020

Correspondence Address:
Pathum Sookaromdee
TWS Medical Center, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.AIAN_280_20

Rights and Permissions

 



How to cite this article:
Sookaromdee P, Wiwanitkit V. COVID-19 and underlying cerebrovascular disease: Analysis on association. Ann Indian Acad Neurol 2020;23, Suppl S1:43-4

How to cite this URL:
Sookaromdee P, Wiwanitkit V. COVID-19 and underlying cerebrovascular disease: Analysis on association. Ann Indian Acad Neurol [serial online] 2020 [cited 2020 May 31];23, Suppl S1:43-4. Available from: http://www.annalsofian.org/text.asp?2020/23/7/43/282797




Dear Editor,

COVID-19 is a new emerging viral disease that can cause severe respiratory distress. The first patient was reported in Wuhan within the Republic of China,[1] before the disease widespread around the world. The underlying illness is reported for association with severity of COVID-19. Regarding cerebrovascular disease, a Chinese report showed that it is a risk factor for severe COVID-19 infection.[2]

Here, the author would like to present additional data from the second country that the new disease had occurred since early January 2020, Thailand.[3] At present (8th April 2020), the total number of COVID-19 patients with 30 deaths in Thailand is 2,369. Two (0.08%) from all COVID-19 patients have underlying cerebrovascular diseases. Focusing on association between underlying cerebrovascular disease and mortality [Table 1]. The preliminary observation from our setting did not support the association between having underlying cerebrovascular disease and poor outcome of COVID-19. Further analysis based on more data from international settings is recommended to clarify the exact clinical relationship between COVID-19 and cerebrovascular disease.
Table 1: Association between underlying cerebrovascular disease and mortality


Click here to view


Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.  Back to cited text no. 1
    
2.
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: Evidence from meta-analysis. Aging (Albany NY). 2020 Apr 8;12. doi: 10.18632/aging. 103000. [Epub ahead of print].  Back to cited text no. 2
    
3.
Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2.  Back to cited text no. 3
    



 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (283 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References
    Article Tables

 Article Access Statistics
    Viewed196    
    Printed1    
    Emailed0    
    PDF Downloaded31    
    Comments [Add]    

Recommend this journal